About this episode
The episode discusses the recent measures taken by the RBI to address the rupee's depreciation and their potential impact on foreign capital inflows.
The rupee has been on a sharp slide, moving from 90 to nearly 97 in just a few months. On Friday, the RBI stepped in with two major measures a concessional FCNR deposit window for NRIs and a subsidised swap facility for ECB borrowings by PSUs effectively absorbing the hedging costs to pull in foreign capital. But how much of a difference will it make, and for how long? Host Rozebud Gonsalves speaks with Sakshi Gupta, Principal Economist at HDFC Bank, on the rupee's initial reaction, expected capital inflows and the forward book. You can follow Rozebud Gonsalves on his social media: X and Linkedin Check out other interesting episodes like: ET Deep Dive: Swipe Left on Reality , India wants manufacturing at 25% of GDP — will AI in factories help? , Tanay Kothari Wants To Kill The Keyboard , From Doer to Director: The LinkedIn Playbook for the AI Agea , Semaglutide Goes Generic: Big Pharma’s Moat Breaks and much more . Catch the latest episode of ‘The Morning Brief’ on The Economic Times Online , Spotify , Apple Podcasts , JioSaavn , Amazon Music and Youtube . See omnystudio.com/listener for privacy information.
People in this episode
Host: Rozebud Gonsalves
Guest: Sakshi Gupta
Topics covered
- Rupee depreciation
- RBI measures
- Foreign capital inflows
- Economics
- Financial markets
Keywords
- Rupee
- RBI
- foreign capital
- economics
- HDFC Bank
Mentioned in this episode
Organizations: HDFC Bank, RBI, The Economic Times
More episodes of The Morning Brief
- How Long Should You Stay in an SIP? · June 12, 2026 · 14 min
- The Gold That Wasn't There: Inside SEBI's Case Against Rajesh Exports · June 9, 2026 · 18 min
- Zia Mody On Law, Legacy and Leadership · June 8, 2026 · 25 min
- ET Deep Dive: Lock, Stock and Worry · June 7, 2026 · 13 min
- Anthropic Goes Public: Can Markets Justify a $1 Trillion Value? · June 5, 2026 · 17 min
- Habil Khorakiwala on India's First FDA-Approved Antibiotic. · June 4, 2026 · 30 min
Explore listener stats, chart rankings, contacts and more on the The Morning Brief podcast page.